Retinoid Acid Inhibits IL-1-Induced iNOS, COX-2 and Chemokine Production in Human Chondrocytes

REFERENCES

• Abulencia J. P., Gaspard R., Healy Z. R., Gaarde W. A., Quackenbush J., Konstantopoulos K. Shear-induced cyclooxygenase-2 via a JNK2/c-Jun-dependent pathway regulates prostaglandin receptor expression in chondrocytic cells. J. Biol. Chem. 2003; 278: 28388–28394
   PubMed Web of Science ®Google Scholar
• Aida Y., Maeno M., Suzuki N., Namba A., Motohashi M., Matsumoto M., Makimura M., Matsumura H. The effect of IL-1beta on the expression of inflammatory cytokines and their receptors in human chondrocytes. Life Sci. 2006; 79: 764–771
   PubMed Web of Science ®Google Scholar
• Aida Y., Maeno M., Suzuki N., Shiratsuchi H., Motohashi M., Matsumura H. The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sci. 2005; 77: 3210–3221
   PubMed Web of Science ®Google Scholar
• Akimoto H., Yamazaki R., Hashimoto S., Sato T., Ito A. 4′-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. Euro. J. Pharmacol. 2000; 401: 429–436
   PubMed Web of Science ®Google Scholar
• Alaaeddine N., Olee T., Hashimoto S., Creighton-Achermann L., Lotz M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation.[see comment]. Arthritis Rheumat. 2001; 44: 1633–1643
   PubMed Web of Science ®Google Scholar
• Attur M. G., Dave M., Cipolletta C., Kang P., Goldring M. B., Patel I. R., Abramson S. B., Amin A. R. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J. Biol. Chem. 2000; 275: 40307–40315
   PubMed Web of Science ®Google Scholar
• Bogoyevitch M. A., Boehm I., Oakley A., Ketterman A. J., Barr R. K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 2004; 1697: 89–101
   PubMed Web of Science ®Google Scholar
• Borzi R. M., Mazzetti I., Cattini L., Uguccioni M., Baggiolini M., Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheumat. 2000; 43: 1734–1741
   PubMed Web of Science ®Google Scholar
• Borzi R. M., Mazzetti I., Macor S., Silvestri T., Bassi A., Cattini L., Facchini A. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett. 1999; 455: 238–242
   PubMed Web of Science ®Google Scholar
• Brand C., Snaddon J., Bailey M., Cicuttini F. Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study. Ann. Rheumatic Dis. 2001; 60: 946–949
   PubMed Web of Science ®Google Scholar
• Castor C. W., Smith E. M., Bignall M. C., Hossler P. A. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network. J. Rheumatol. 1997; 24: 2080–2089
   PubMed Web of Science ®Google Scholar
• Chen Q., Liu S. Q., Du Y. M., Peng H., Sun L. P. Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta-induced apoptosis. Euro. J. Pharmacol. 2006; 541: 1–8
   PubMed Web of Science ®Google Scholar
• Choi H. K. Dietary risk factors for rheumatic diseases. Curr. Opin. Rheumatol. 2005; 17: 141–146
   PubMed Web of Science ®Google Scholar
• Chu C. R., Kaplan L. D., Fu F. H., Crossett L. S., Studer R. K. Recovery of articular cartilage metabolism following thermal stress is facilitated by IGF-1 and JNK inhibitor. Amer. J. Sports Med. 2004; 32: 191–196
   PubMed Web of Science ®Google Scholar
• Fanning P. J., Emkey G., Smith R. J., Grodzinsky A. J., Szasz N., Trippel S. B. Mechanical regulation of mitogen-activated protein kinase signaling in articular cartilage. J. Biol. Chem. 2003; 278: 50940–50948
   PubMed Web of Science ®Google Scholar
• Gaby A. R. Alternative treatments for rheumatoid arthritis. Altern. Med. Rev. 1999; 4: 392–402
   PubMedGoogle Scholar
• Gemba T., Valbracht J., Alsalameh S., Lotz M. Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment. J. Biol. Chem. 2002; 277: 907–911
   PubMed Web of Science ®Google Scholar
• Goldberg V. M., Kresina T. F. Immunology of articular cartilage. J. Rheumatol. 1987; 14 Spec: 73–76
   Web of Science ®Google Scholar
• Hashimoto S., Takahashi K., Amiel D., Coutts R. D., Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheumat. 1998; 41: 1266–1274
   PubMed Web of Science ®Google Scholar
• Hisada T., Adcock I. M., Nasuhara Y., Salmon M., Huang T. J., Barnes P. J., Chung K. F. Inhibition of ozone-induced lung neutrophilia and nuclear factor-kappaB binding activity by vitamin A in rat. Euro. J. Pharmacol. 1999; 377: 63–68
   PubMed Web of Science ®Google Scholar
• Ho L. J., Lin L. C., Hung L. F., Wang S. J., Lee C. H., Chang D. M., Lai J. H., Tai T. Y. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochem. Pharmacol. 2005; 70: 200–208
   PubMed Web of Science ®Google Scholar
• Kerin A., Patwari P., Kuettner K., Cole A., Grodzinsky A. Molecular basis of osteoarthritis: biomechanical aspects. Cell. Mol. Life Sci. 2002; 59: 27–35
   PubMed Web of Science ®Google Scholar
• Lai J. H., Ho L. J., Lu K. C., Chang D. M., Shaio M. F., Han S. H. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 2001; 166: 6914–6924
   PubMed Web of Science ®Google Scholar
• Langmann T., Liebisch G., Moehle C., Schifferer R., Dayoub R., Heiduczek S., Grandl M., Dada A., Schmitz G. Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim. Biophys. Acta 2005; 1740: 155–161
   PubMed Web of Science ®Google Scholar
• Leboy P., Grasso-Knight G., D'Angelo M., Volk S. W., Lian J. V., Drissi H., Stein G. S., Adams S. L. Smad-Runx interactions during chondrocyte maturation. J. Bone Joint Surg. Amer. 2001; 83-A(Suppl 1)S15–22
   Google Scholar
• Lee M. S., Ikenoue T., Trindade M. C., Wong N., Goodman S. B., Schurman D. J., Smith R. L. Protective effects of intermittent hydrostatic pressure on osteoarthritic chondrocytes activated by bacterial endotoxin in vitro. J. Ortho. Res. 2003; 21: 117–122
   PubMed Web of Science ®Google Scholar
• Liacini A., Sylvester J., Li W. Q., Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 2002; 21: 251–262
   PubMed Web of Science ®Google Scholar
• Malemud C. J. Cytokines as therapeutic targets for osteoarthritis. BioDrugs 2004; 18: 23–35
   PubMed Web of Science ®Google Scholar
• Mazzetti I., Magagnoli G., Paoletti S., Uguccioni M., Olivotto E., Vitellozzi R., Cattini L., Facchini A., Borzi R. M. A role for chemokines in the induction of chondrocyte phenotype modulation. Arthritis Rheumat. 2004; 50: 112–122
   PubMedGoogle Scholar
• Meulenbelt I., Seymour A. B., Nieuwland M., Huizinga T. W., van Duijn C. M., Slagboom P. E. Association of the interleukin-1 gene cluster with radiographic signs of osteoarthritis of the hip. Arthritis Rheumat. 2004; 50: 1179–1186
   PubMed Web of Science ®Google Scholar
• Murrell G. A., Jang D., Williams R. J. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 1995; 206: 15–21
   PubMed Web of Science ®Google Scholar
• Notoya K., Jovanovic D. V., Reboul P., Martel-Pelletier J., Mineau F., Pelletier J. P. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J. Immunol. 2000; 165: 3402–3410
   PubMed Web of Science ®Google Scholar
• Nozaki Y., Yamagata T., Sugiyama M., Ikoma S., Kinoshita K., Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin. Immunol. 2006; 119: 272–279
   PubMed Web of Science ®Google Scholar
• Pelletier J. P., DiBattista J. A., Roughley P., McCollum R., Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheumat. Dis. Clin. North Amer. 1993; 19: 545–568
   PubMed Web of Science ®Google Scholar
• Pelletier J. P., Fernandes J. C., Jovanovic D. V., Reboul P., Martel-Pelletier J. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J. Rheumatol. 2001a; 28: 2509–2519
   Web of Science ®Google Scholar
• Pelletier J. P., Jovanovic D., Fernandes J. C., Manning P., Connor J. R., Currie M. G., Di Battista J. A., Martel-Pelletier J. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheumat. 1998; 41: 1275–1286
   PubMed Web of Science ®Google Scholar
• Pelletier J. P., Jovanovic D. V., Lascau-Coman V., Fernandes J. C., Manning P. T., Connor J. R., Currie M. G., Martel-Pelletier J. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheumat. 2000; 43: 1290–1299
   PubMed Web of Science ®Google Scholar
• Pelletier J. P., Martel-Pelletier J., Abramson S. B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. [see comment]. Arthritis Rheumat. 2001b; 44: 1237–1247
   PubMed Web of Science ®Google Scholar
• Pujol J. P., Loyau G. Interleukin-1 and osteoarthritis. Life Sci. 1987; 41: 1187–1198
   PubMed Web of Science ®Google Scholar
• Pulsatelli L., Dolzani P., Piacentini A., Silvestri T., Ruggeri R., Gualtieri G., Meliconi R., Facchini A. Chemokine production by human chondrocytes. J. Rheumatol. 1999; 26: 1992–2001
   PubMed Web of Science ®Google Scholar
• Ranganathan A. C., Nelson K. K., Rodriguez A. M., Kim K. H., Tower G. B., Rutter J. L., Brinckerhoff C. E., Huang T. T., Epstein C. J., Jeffrey J. J., Melendez J. A. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. J. Biol. Chem. 2001; 276: 14264–14270
   PubMed Web of Science ®Google Scholar
• Reimold A. M. TNFalpha as therapeutic target: new drugs, more applications. Curr. Drug Targets Inflam. Allergy 2002; 1: 377–392
   PubMedGoogle Scholar
• Schroen D. J., Brinckerhoff C. E. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun. J. Cell. Physiol. 1996; 169: 320–332
   PubMed Web of Science ®Google Scholar
• Singh R., Ahmed S., Malemud C. J., Goldberg V. M., Haqqi T. M. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J. Orthopaed. Res. 2003; 21: 102–109
   PubMed Web of Science ®Google Scholar
• Sowers M., Lachance L. Vitamins and arthritis. The roles of vitamins A, C, D, and E. Rheumat. Dis. Clin. N. Amer. 1999; 25: 315–332
   PubMed Web of Science ®Google Scholar
• Torii A., Miyake M., Morishita M., Ito K., Torii S., Sakamoto T. Vitamin A reduces lung granulomatous inflammation with eosinophilic and neutrophilic infiltration in Sephadex-treated rats. Euro. J. Pharmacol. 2004; 497: 335–342
   PubMed Web of Science ®Google Scholar
• Vaillancourt F., Morquette B., Shi Q., Fahmi H., Lavigne P., Di Battista J. A., Fernandes J. C., Benderdour M. Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade. J. Cell. Biochem. 2007; 100: 1217–1231
   PubMed Web of Science ®Google Scholar
• van den Berg W. B. Lessons from animal models of osteoarthritis. Curr. Opin. Rheumatol. 2001; 13: 452–456
   PubMed Web of Science ®Google Scholar
• Xu Q., Konta T., Furusu A., Nakayama K., Lucio-Cazana J., Fine L. G., Kitamura M. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J. Biol. Chem. 2002; 277: 41693–41700
   PubMed Web of Science ®Google Scholar
• Yang S. P., Ho L. J., Lin Y. L., Cheng S. M., Tsao T. P., Chang D. M., Hsu Y. L., Shih C. Y., Juan T. Y., Lai J. H. Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc. Res. 2003; 59: 776–787
   PubMed Web of Science ®Google Scholar
• Yuan G. H., Masuko-Hongo K., Sakata M., Tsuruha J., Onuma H., Nakamura H., Aoki H., Kato T., Nishioka K. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheumat. 2001; 44: 1056–1070
   PubMed Web of Science ®Google Scholar
• Zochling J., March L., Lapsley H., Cross M., Tribe K., Brooks P. Use of complementary medicines for osteoarthritis—a prospective study. Ann. Rheumat. Dis. 2004; 63: 549–554
   PubMed Web of Science ®Google Scholar